Neurosurgery News and Research RSS Feed - Neurosurgery News and Research

Misonix net sales increase 36% to $5.6 million in second quarter fiscal 2015

Misonix net sales increase 36% to $5.6 million in second quarter fiscal 2015

Misonix, Inc., an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced financial results for the second quarter of fiscal 2015, ended December 31, 2014. [More]
Two new fluorescent dyes may help localize, resect brain tumors

Two new fluorescent dyes may help localize, resect brain tumors

Two new fluorescent dyes attracted to cancer cells may help neurosurgeons more accurately localize and completely resect brain tumors, suggests a study in the February issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. [More]
Survey results shows meningioma survivors more likely to want and intend to have baby

Survey results shows meningioma survivors more likely to want and intend to have baby

The diagnosis of a brain tumor—even one that's usually "benign" and slow growing such as a meningioma—can be scary. [More]
Survey shows that vast majority of US neurosurgeons participate in defensive medicine

Survey shows that vast majority of US neurosurgeons participate in defensive medicine

More than three-fourths US neurosurgeons practice some form of defensive medicine--performing additional tests and procedures out of fear of malpractice lawsuits, reports a special article in the February issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. [More]
New eye-tracking device measures severity of concussion and brain injury

New eye-tracking device measures severity of concussion and brain injury

New research out of NYU Langone Medical Center could move the medical community one step closer toward effectively detecting concussion and quantifying its severity. [More]
Clear and concise communication essential to quality patient care in ED

Clear and concise communication essential to quality patient care in ED

The high-risk, rapidly changing nature of hospital Emergency Departments creates an environment where stress levels and staff burnout rates are high, but researchers at St. Michael's Hospital have identified the secret sauce that helps many emergency clinicians flourish - communication. [More]
Researchers discover novel compound that helps curtail progression of temporal lobe epilepsy

Researchers discover novel compound that helps curtail progression of temporal lobe epilepsy

Researchers at the LSU Health New Orleans Neuroscience Center of Excellence have found that a novel compound they discovered helps curtail the onset and progression of temporal lobe epilepsy. [More]
Majority of Canada's homeless adults with mental illness show evidence of cognitive deficits

Majority of Canada's homeless adults with mental illness show evidence of cognitive deficits

Nearly three-quarters of homeless adults with mental illness in Canada show evidence of cognitive deficits, such as difficulties with problem solving, learning and memory, new research has found. [More]
Study uses 'systems genetics' approach to identify potential target for epilepsy

Study uses 'systems genetics' approach to identify potential target for epilepsy

A single gene that coordinates a network of about 400 genes involved in epilepsy could be a target for new treatments, according to research. [More]
Elekta updates latest R&D work with special focus on high field MRI-guided radiation therapy

Elekta updates latest R&D work with special focus on high field MRI-guided radiation therapy

Elekta updated the market this morning on its latest research and development initiatives, with special focus on Atlantic, the first generation high field MRI-guided radiation therapy system. The company unveiled plans to introduce this game-changing technology in 2017 and deliver the first systems in 2018. [More]
Cohera Medical, B. Braun sign sales and distribution agreement for TissuGlu Surgical Adhesive

Cohera Medical, B. Braun sign sales and distribution agreement for TissuGlu Surgical Adhesive

Cohera Medical, Inc., a leading innovator and developer of absorbable surgical adhesives and sealants, announced today that it has entered into an exclusive sales and marketing distribution agreement with B. Braun for its TissuGlu Surgical Adhesive in Germany, Spain and Portugal. [More]
Stomach ulcer bug H. pylori may reduce risk of developing multiple sclerosis

Stomach ulcer bug H. pylori may reduce risk of developing multiple sclerosis

A West Australian team has found evidence that the stomach ulcer bacterium, Helicobacter pylori, is associated with a lower risk of multiple sclerosis (MS), bolstering evidence for the role of the ‘hygiene hypothesis’ in autoimmune disorders. [More]
Study suggests that common gut microbe may control risk of developing MS

Study suggests that common gut microbe may control risk of developing MS

A common gut microbe might curb the risk of developing multiple sclerosis--at least in women--suggests the largest study of its kind published online in the Journal of Neurology Neurosurgery & Psychiatry. [More]
Elekta helps new Australian cancer center make seamless transition to MOSAIQ OIS

Elekta helps new Australian cancer center make seamless transition to MOSAIQ OIS

As part of consolidating the cancer care of four Western Australian public services into a single, multi-disciplinary facility, the clinics will transition from their existing oncology information systems (OIS) to Elekta's MOSAIQ OIS. [More]
Protecting children in advance from head injuries helps reduce brain trauma

Protecting children in advance from head injuries helps reduce brain trauma

An exhaustive analysis of data from more than 40,000 cases of brain trauma in children - published by the authoritative New England Journal of Medicine - provides convincing evidence that protecting children in advance from head injuries is the key to reducing their severity. [More]
Researchers examine ischemic complications in patients who receive flow-diverting stents

Researchers examine ischemic complications in patients who receive flow-diverting stents

The use of flow-diverting stents to treat intracranial aneurysms appears safe and highly successful. Recently, however, there have been reports of ischemic complications occurring in brain territories supplied by the parent artery in which the stent is placed and in brain regions fed by small arterial branches whose ostia are covered by the stent. [More]
Using laparoscopy for VP shunt placement can decrease rate of distal shunt failures

Using laparoscopy for VP shunt placement can decrease rate of distal shunt failures

Researchers conducted a prospective randomized controlled clinical trial at Bern University Hospital in Switzerland to compare a laparoscopic procedure with a mini-laparotomy for insertion of a peritoneal catheter during ventriculoperitoneal (VP) shunt surgery. The deciding factor was the rate of shunt malfunction. [More]
Elekta's Flexitron brachytherapy afterloading platform approved in China

Elekta's Flexitron brachytherapy afterloading platform approved in China

Elekta announces that the China Food and Drug Administration has approved Elekta's Flexitron brachytherapy afterloading platform for sale and marketing in China. [More]
SPECT scan measures brain activity during seizures

SPECT scan measures brain activity during seizures

Loyola University Medical Center is offering epileptic patients an imaging scan that records brain activity during seizures. [More]
Intra-arterial stroke treatment more effective than medical management with tPA, study finds

Intra-arterial stroke treatment more effective than medical management with tPA, study finds

Penumbra, Inc., the market leader in intra-arterial stroke treatment, announced that an independent study published online today in the New England Journal of Medicine found that intra-arterial stroke treatment, including the company's clot extraction technology, was shown to be significantly more effective than medical management with tissue plasminogen activator (tPA), which is the current standard of care. [More]